# PERSEVERE- A Trial to Evaluate AMDS in Acute DeBakey Type I Dissection

Study · id `cardio:ct-nct05174767` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05174767](<https://clinicaltrials.gov/study/NCT05174767>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT05174767

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 115 participants.

## Technical summary

Registry record NCT05174767. Allocation not applicable; no masking; primary purpose treatment. Start 2022-05-27 (actual); primary completion 2023-12-11 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 115 participants (enrolled count; ClinicalTrials.gov record NCT05174767, source copy `cardio:ctgov-nct05174767-2025-01-15`, retrieved 2026-11-18)
- Started: 2022-05-27 (actual) (ClinicalTrials.gov record NCT05174767, source copy `cardio:ctgov-nct05174767-2025-01-15`, retrieved 2026-11-18)
- Primary completion: 2023-12-11 (actual) (ClinicalTrials.gov record NCT05174767, source copy `cardio:ctgov-nct05174767-2025-01-15`, retrieved 2026-11-18)
- Completion: 2029-12-06 (anticipated) (ClinicalTrials.gov record NCT05174767, source copy `cardio:ctgov-nct05174767-2025-01-15`, retrieved 2026-11-18)
- Countries: United States (ClinicalTrials.gov record NCT05174767, source copy `cardio:ctgov-nct05174767-2025-01-15`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05174767-2025-01-15`, retrieved 2026-11-18)

## The registry's words

- Brief title: PERSEVERE- A Trial to Evaluate AMDS in Acute DeBakey Type I Dissection
- Acronym: PERSEVERE
- Condition: Acute Aortic Dissection
- Intervention (Device): AMDS
- Lead sponsor: Artivion Inc.
- Lead sponsor class: INDUSTRY
- Collaborator: Syneos Health
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Aortic dissection (`cardio:aortic-dissection`)
- Registry lists this organization as the lead sponsor: Artivion Inc. (`cardio:org-artivion-inc`)
- Registry lists this organization as a collaborator: Syneos Health (`cardio:org-syneos-health`)

## Provenance

Content hash: acce49b2bef800f83e8cf65b41738451a1b87080a864ed1aecd6c6a1de80375f
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
